AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3104051 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid antacid preparation 1
Number of subjects: 0
Study 3104051 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid antacid preparation 2
Number of subjects: 0
Study 3104051 — intervention group
Group type: COMPARATOR
Intervention: Preference study
Number of subjects: 0
Study 3104051 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for preference
Number of subjects: 0
Study 31634188 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral flow assay (LFA) measuring tenofovir adherence
Number of subjects: 300
Study 31634188 — intervention group
Group type: COMPARATOR
Intervention: LC-MS/MS (gold-standard method)
Number of subjects: 300
Study 29358194 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment with higher HDL cholesterol levels at month 3
Number of subjects: 9542
Study 26888227 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg for the first dose and then 200 mg)
Number of subjects: 160
Study 26888227 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxoprofen (60 mg)
Number of subjects: 160
Study 26888227 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (600 mg)
Number of subjects: 160
Study 24378207 — intervention group
Group type: EXPERIMENTAL
Intervention: DP-R206 (150-mg ibandronate/24,000-IU vitamin D3 tablet)
Number of subjects: 36
Study 24378207 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 24,000-IU tablet (reference drug)
Number of subjects: 36
Study 21553939 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-initiated physical activity
Number of subjects: 106
Study 20877353 — intervention group
Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 796
Study 20877353 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU+FA
Number of subjects: 796
Study 20877353 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU+IFNα
Number of subjects: 796
Study 18794697 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal trumpet
Number of subjects: 100
Study 18794697 — intervention group
Group type: COMPARATOR
Intervention: Fecal collector
Number of subjects: 100
Study 18794697 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 16094218 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV vaccine (high potency)
Number of subjects: 1559
Study 16094218 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV vaccine (any varicella potency)
Number of subjects: 1559
Study 16094218 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV vaccine (1 or 2 injections)
Number of subjects: 1559
Study 16094218 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV vaccine (second injection)
Number of subjects: 1559
Study 16094218 — intervention group
Group type: COMPARATOR
Intervention: Concomitant administration of M-M-RII and VARIVAX
Number of subjects: 1559
Study 16094218 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV vaccine
Number of subjects: 1559
Study 12571431 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone monotherapy
Number of subjects: 0
Study 12571431 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment with amitriptyline and haloperidol
Number of subjects: 0
Study 10561963 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine cream for 1 week
Number of subjects: 48
Study 10561963 — intervention group
Group type: COMPARATOR
Intervention: Miconazole cream for 4 weeks
Number of subjects: 48
Study 8678082 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX 160/800 mg orally every 12 hours for 2 months
Number of subjects: 54
Study 8678082 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 54
Study 1283588 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 54
Study 1283588 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 54
Study 1283588 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Verapamil and Enalapril
Number of subjects: 54
Study 1283588 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil or Enalapril
Number of subjects: 54
Study 6584451 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard toothbrush with bristle thickness of 0.23 mm
Number of subjects: 24
Study 6584451 — intervention group
Group type: COMPARATOR
Intervention: Soft toothbrush with bristle thickness of 0.15 mm
Number of subjects: 24
Study 6584451 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrasive dentifrice
Number of subjects: 24
Study 6584451 — intervention group
Group type: COMPARATOR
Intervention: No dentifrice
Number of subjects: 24
Study 6584451 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately abrasive toothpaste
Number of subjects: 24
Study 30916886 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral tarsal strip with everting sutures (LTS + ES)
Number of subjects: 52
Study 30916886 — intervention group
Group type: COMPARATOR
Intervention: Quickert procedure (QP)
Number of subjects: 52
Study 28217941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-mode survey methods (Internet-based and postal)
Number of subjects: 0
Study 28217941 — intervention group
Group type: COMPARATOR
Intervention: Postal-only survey methods
Number of subjects: 0
Study 27418270 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant girentuximab treatment
Number of subjects: 845
Study 27418270 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 30-34.9
Number of subjects: 845
Study 27418270 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥35
Number of subjects: 845
Study 23862586 — intervention group
Group type: COMPARATOR
Intervention: Two-layer microsurgical vasovasostomy (TLMVV)
Number of subjects: 206
Study 23862586 — intervention group
Group type: EXPERIMENTAL
Intervention: Macroscopic one-layer vasovasostomy (MOLVV)
Number of subjects: 206
Study 21555676 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg
Number of subjects: 1094
Study 21555676 — intervention group
Group type: COMPARATOR
Intervention: Usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg
Number of subjects: 1094
Study 20143923 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphatic microsurgical procedures or tissue debulking with special staining techniques
Number of subjects: 0
Study 16710287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of irbesartan (ARB) and ramipril (ACE inhibitor)
Number of subjects: 0
Study 16710287 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (ACE inhibitor) alone
Number of subjects: 0
Study 15587588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrothricin (0.1 g tyrothricin per 100 g of vehicle) applied twice daily for 9 days
Number of subjects: 131
Study 15587588 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder applied twice daily for 9 days
Number of subjects: 131
Study 11378187 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 70
Study 11378187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 9215784 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary 125I implants with a median reference dose of 60 Gy
Number of subjects: 515
Study 9215784 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent 125I implants with a median reference dose of 100 Gy
Number of subjects: 515
Study 9215784 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary implants
Number of subjects: 515
Study 9215784 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 Gy isodose volume <4.5 ml
Number of subjects: 515
Study 9215784 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 Gy isodose volume >4.5 ml
Number of subjects: 515
Study 8485323 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN) with high lipid content
Number of subjects: 18
Study 8485323 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 18
Study 3609119 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU 7.5 mg/kg
Number of subjects: 6
Study 3609119 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU 15 mg/kg
Number of subjects: 6
Study 3609119 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU 7.5 mg/kg and 15 mg/kg
Number of subjects: 6
Study 3609119 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU
Number of subjects: 6
Study 29080044 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice a day for 3 months
Number of subjects: 48
Study 29080044 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice a day for 3 months
Number of subjects: 48
Study 26515021 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a larger social network (8 speakers)
Number of subjects: 0
Study 26515021 — intervention group
Group type: COMPARATOR
Intervention: Exposure to a smaller social network (2 speakers)
Number of subjects: 0
Study 24047644 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month physical activity stimulation programme involving counselling through motivational interviewing, home-based physiotherapy and four months of fitness training.
Number of subjects: 49
Study 24047644 — intervention group
Group type: COMPARATOR
Intervention: Regular paediatric physiotherapy (Control group).
Number of subjects: 49
Study 23307962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flicker stimulation in diabetic patients
Number of subjects: 100
Study 23307962 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Doppler velocimetry in diabetic patients
Number of subjects: 100
Study 23307962 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern electroretinography (ERG)
Number of subjects: 100
Study 20621334 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation response training (RR)
Number of subjects: 168
Study 20621334 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthritis education (AE)
Number of subjects: 168
Study 20621334 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavior therapy (CBT)
Number of subjects: 168
Study 20621334 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups aggregated
Number of subjects: 168
Study 18676087 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg micronized progesterone for 21 days
Number of subjects: 10
Study 18676087 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study 20192924 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test performed at the 12th week of gestation
Number of subjects: 745
Study 20192924 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test
Number of subjects: 745
Study 20192924 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical screening and ultrasonographic markers
Number of subjects: 745
Study 20192924 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test at 11-13+6 weeks' gestation
Number of subjects: 745
Study 16361638 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 150 U/kg subcutaneously 3 times weekly until 3 weeks after completion of chemotherapy
Number of subjects: 224
Study 16361638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 16361638 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 224
Study 12479890 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 49
Study 12479890 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 49
Study 9630831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 34
Study 9630831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 8160250 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluphenazine dihydrochloride 5 mg
Number of subjects: 37
Study 8160250 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluphenazine dihydrochloride 10 mg
Number of subjects: 37
Study 8160250 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluphenazine dihydrochloride 20 mg
Number of subjects: 37
Study 3292710 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate 40 mg orally four times daily
Number of subjects: 138
Study 3292710 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 10 mg orally twice a day
Number of subjects: 138
Study 11277161 — intervention group
Group type: EXPERIMENTAL
Intervention: AWHONN/NANN Neonatal Skin Care Research‐Based Clinical Practice Guideline
Number of subjects: 2820
Study 29457998 — intervention group
Group type: EXPERIMENTAL
Intervention: PR plus quadricipital home‐based NMES (35Hz, 30min, 5 times per week)
Number of subjects: 73
Study 29457998 — intervention group
Group type: COMPARATOR
Intervention: PR without NMES
Number of subjects: 73
Study 26675768 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow cassava (mean content: 1460 μg β‐carotene/d)
Number of subjects: 342
Study 26675768 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐carotene supplement (1053 μg/d)
Number of subjects: 342
Study 26675768 — intervention group
Group type: COMPARATOR
Intervention: White cassava and placebo supplement (control group)
Number of subjects: 342
Study 24813595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon supplements (1.5 g/d)
Number of subjects: 45
Study 24813595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 22066961 — intervention group
Group type: EXPERIMENTAL
Intervention: AQUACEL(®) Ag
Number of subjects: 281
Study 22066961 — intervention group
Group type: COMPARATOR
Intervention: Urgotul(®) Silver
Number of subjects: 281
Study 20039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium levels in hemodialysis patients (HD)
Number of subjects: 103
Study 20039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium levels in continuous ambulatory peritoneal dialysis patients (CAPD)
Number of subjects: 103
Study 20039146 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 103
Study 20039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of selenium levels between HD and CAPD patients
Number of subjects: 103
Study 20039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium levels in spent dialysate effluent fluid of CAPD patients
Number of subjects: 103
Study 18812344 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg x kg(‐1) morphine sulfate interpleurally for 24 hours
Number of subjects: 36
Study 18812344 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine with epinephrine interpleurally for 24 hours
Number of subjects: 36
Study 16047469 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin, 500 mg bd for 12 weeks (n = 6)
Number of subjects: 13
Study 16047469 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks (n = 7)
Number of subjects: 13
Study 12496063 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg/day of red clover-derived dietary isoflavones
Number of subjects: 38
Study 12496063 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 38
Study 10521110 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 422
Study 10521110 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 422
Study 10521110 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related factors
Number of subjects: 422
Study 10521110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleavage status
Number of subjects: 422
Study 7480524 — intervention group
Group type: EXPERIMENTAL
Intervention: ECTx3 (three times weekly electroconvulsive therapy)
Number of subjects: 47
Study 7480524 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (ECTx2 and ECTx3)
Number of subjects: 47
Study 7480524 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT (any group)
Number of subjects: 47
Study 7480524 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment
Number of subjects: 47
Study 2126420 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g MCT/LCT fats twice weekly
Number of subjects: 3
Study 2126420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 g/kg body weight per day MCT/LCT fats
Number of subjects: 3
Study 2126420 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/kg body weight per day MCT/LCT fats
Number of subjects: 3
Study 760752 — intervention group
Group type: EXPERIMENTAL
Intervention: BW501 100 mg
Number of subjects: 24
Study 760752 — intervention group
Group type: EXPERIMENTAL
Intervention: BW501 10 mg
Number of subjects: 24
Study 760752 — intervention group
Group type: EXPERIMENTAL
Intervention: BW501 2 mg
Number of subjects: 24
Study 760752 — intervention group
Group type: EXPERIMENTAL
Intervention: Methysergide 2 mg
Number of subjects: 24
Study 760752 — intervention group
Group type: COMPARATOR
Intervention: No drug (control)
Number of subjects: 24
Study 30449171 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized diet (1.2‐1.5 g/kg of protein, 30% of energy from fat, 55‐60% of energy from carbohydrate), face to face nutrition education, pamphlet with nutrition information
Number of subjects: 150
Study 30449171 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized diet, face to face nutrition education, pamphlet with nutrition information
Number of subjects: 150
Study 30449171 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 150
Study 30373993 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) in standing posture
Number of subjects: 20
Study 30373993 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) in seated posture
Number of subjects: 20
Study 30373993 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV)
Number of subjects: 20
Study 28586607 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 5 days
Number of subjects: 100
Study 28586607 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment for 5 days
Number of subjects: 100
Study 28586607 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic treatment
Number of subjects: 100
Study 28586607 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic treatment
Number of subjects: 100
Study 24140659 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1108
Study 24140659 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1108
Study 24140659 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 1108
Study 22318197 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 20 mg
Number of subjects: 38
Study 22318197 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 38
Study 20673892 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose human chorionic gonadotropin (hCG)
Number of subjects: 0
Study 20673892 — intervention group
Group type: COMPARATOR
Intervention: Estradiol/progesterone (E(2)/P)
Number of subjects: 0
Study 17404369 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (2 cycles of carboplatin AUC 6 and paclitaxel 200 mg/m2 every 21 days) followed by concurrent chemoradiotherapy (66 Gy of chest radiotherapy with carboplatin AUC 2 and paclitaxel 50 mg/m2 weekly)
Number of subjects: 366
Study 17404369 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy alone (66 Gy of chest radiotherapy with carboplatin AUC 2 and paclitaxel 50 mg/m2 weekly)
Number of subjects: 366
Study 15798610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fibrinolysis (IVF) with urokinase 900,000 units
Number of subjects: 27
Study 15798610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial fibrinolysis (IAF) with urokinase 900,000 units
Number of subjects: 27
Study 15798610 — intervention group
Group type: COMPARATOR
Intervention: Primary outcome: modified Rankin score of 2 or less
Number of subjects: 27
Study 15798610 — intervention group
Group type: COMPARATOR
Intervention: Secondary outcomes: mortality, frequency of symptomatic intracranial haemorrhage (SIH), neurological and functional scores
Number of subjects: 27
Study 12030662 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessment by the community mental health team (CMHT)
Number of subjects: 93
Study 12030662 — intervention group
Group type: COMPARATOR
Intervention: Routine general practitioner (GP) care
Number of subjects: 93
Study 11403352 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 weeks of exercise training
Number of subjects: 39
Study 11403352 — intervention group
Group type: COMPARATOR
Intervention: Control program
Number of subjects: 39
Study 9513907 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus chlorambucil
Number of subjects: 87
Study 9513907 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus cyclophosphamide
Number of subjects: 87
Study 9513907 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 87
Study 8139992 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal AV delay (100-250 msec)
Number of subjects: 12
Study 8139992 — intervention group
Group type: COMPARATOR
Intervention: Most unfavorable AV delay
Number of subjects: 12
Study 8139992 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal AV delay
Number of subjects: 12
Study 3260641 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 44
Study 3260641 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-electrically stimulated spastics)
Number of subjects: 44
Study 5484103 — intervention group
Group type: EXPERIMENTAL
Intervention: High-arousal group (exposed to infantile oral objects)
Number of subjects: 48
Study 5484103 — intervention group
Group type: COMPARATOR
Intervention: Low-arousal group (believed they only had to blow on whistles or pipes)
Number of subjects: 48
Study 30915458 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS4 (4 weeks of full feeding with cassava meal)
Number of subjects: 216
Study 30915458 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS5 (5 weeks of full feeding with cassava meal)
Number of subjects: 216
Study 30915458 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS6 (6 weeks of full feeding with cassava meal)
Number of subjects: 216
Study 30915458 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (CAS4, CAS5, CAS6)
Number of subjects: 216
Study 29219093 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellphone reminder/recall intervention
Number of subjects: 595